These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [The management of chronic asthma with inhaled beta 2 agonists--regular use? symptomatic use?]. Kitamura S; Sugama Y Nihon Rinsho; 1996 Nov; 54(11):3078-80. PubMed ID: 8950958 [TBL] [Abstract][Full Text] [Related]
8. The use of inhaled formoterol in the treatment of asthma. Berger WE Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777 [TBL] [Abstract][Full Text] [Related]
9. Controversies involving inhaled beta-agonists and inhaled corticosteroids in the treatment of asthma. Fahy JV; Boushey HA Clin Chest Med; 1995 Dec; 16(4):715-33. PubMed ID: 8565410 [TBL] [Abstract][Full Text] [Related]
10. Rescue treatment in asthma. More than as-needed bronchodilation. Papi A; Caramori G; Adcock IM; Barnes PJ Chest; 2009 Jun; 135(6):1628-1633. PubMed ID: 19497897 [TBL] [Abstract][Full Text] [Related]
12. Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma. Bijl-Hofland ID; Cloosterman SG; Folgering HT; van den Elshout FJ; van Weel C; van Schayck CP Am J Respir Crit Care Med; 2001 Sep; 164(5):764-9. PubMed ID: 11549530 [TBL] [Abstract][Full Text] [Related]
13. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response. Peters S Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066 [TBL] [Abstract][Full Text] [Related]
14. What is new with the beta2-agonists: issues in the management of asthma. Kelly HW Ann Pharmacother; 2005 May; 39(5):931-8. PubMed ID: 15811904 [TBL] [Abstract][Full Text] [Related]
15. Inhaled beta 2-adrenergic agonists in asthma: the evolving dilemma. Hui KP Singapore Med J; 1994 Jun; 35(3):237-9. PubMed ID: 7997893 [TBL] [Abstract][Full Text] [Related]
16. Asthma medication in Finnish olympic athletes: no signs of inhaled beta2-agonist overuse. Alaranta A; Alaranta H; Palmu P; Alha P; Pietilä K; Heliövaara M; Helenius I Med Sci Sports Exerc; 2004 Jun; 36(6):919-24. PubMed ID: 15179158 [TBL] [Abstract][Full Text] [Related]
17. The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology. Sears MR; Taylor DR Drug Saf; 1994 Oct; 11(4):259-83. PubMed ID: 7848546 [TBL] [Abstract][Full Text] [Related]
18. Low-dose salbutamol suppresses airway responsiveness to histamine but not methacholine in subjects with asthma. Matsumoto K; Aizawa H; Fukuyama S; Yoshida M; Komori M; Takata S; Koto H; Inoue H Respir Investig; 2013 Sep; 51(3):158-65. PubMed ID: 23978642 [TBL] [Abstract][Full Text] [Related]
19. Inhaled beta2 agonists and performance in competitive athletes. Kindermann W; Meyer T Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i43-7. PubMed ID: 16799103 [TBL] [Abstract][Full Text] [Related]
20. Concluding remarks: can we explain the association of beta-agonists with asthma mortality? A hypothesis. Hancox RJ Clin Rev Allergy Immunol; 2006; 31(2-3):279-88. PubMed ID: 17085800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]